SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Dinosol

Dinosol is trending as traders discuss its potential as a Solana project. Community members are performing technical analysis and debating its future, with some expressing bullish sentiment and others warning of potential risks. The coin is gaining attention as it trends, with some anticipating significant growth.

Litecoin is a peer-to-peer cryptocurrency created by Charlie Lee. It was created based on the Bitcoin protocol but differs in terms of the hashing algorithm used. Litecoin uses the memory intensive Scrypt proof of work mining algorithm. Scrypt allows consumer-grade hardware such as GPU to mine those coins.  Why Litecoin? Litecoin is a cryptocurrency that has evolved from Bitcoin after its own popularity in the industry, this alternative, or ‘altcoin’ has emerged to allow investors to diversify their digital currency package, according to Investopedia. Litecoin is one of the most prominent altcoins and was created by former Google employee and Director of Engineering at Coinbase, Charlie Lee. Litecoin was the first to alter Bitcoin and the most significant difference is that it takes 2.5 minutes for Litecoin to generate a block, or transaction, in comparison to Bitcoin's 10 minutes.  ‘While this matters little to traders, miners who use hardware to run Bitcoin's network cannot switch over to Litecoin. This keeps bigger mining conglomerates away from Litecoin because they cannot easily optimize their profits by swapping to another coin, contributing to a more decentralized experience. Litecoin also has bigger blocks, and more coins in circulation, making it more affordable and swift when transacting,’ Investopedia explained.  As explained above, Litecoin can transact a lot faster than Bitcoin, but there are also a number of other characteristics that investors need to know before trading. Litecoin can handle higher volumes of transactions because of the capability of transacting faster and if Bitcoin attempted to transact on the scale of its altcoin, a code update would be needed. However, Litecoin’s blocks would be larger, but with more ‘orphaned blocks'. The faster block time of litecoin reduces the risk of double spending attacks - this is theoretical in the case of both networks having the same hashing power.  Litecoin Technical Details: The transaction confirmation time taken for Litecoin is about 2.5 minutes on average (as compared to Bitcoin's 10 minutes). The Litecoin network is scheduled to cap at 84 million currency units.   Litecoin has inspired many other popular alternative currencies (eg. Dogecoin) because of its Scrypt hashing algorithm in order to prevent ASIC miners from mining those coins. However it is said that by the end of this year, Scrypt ASIC will enter the mass market.

Litecoin

Litecoin is trending as the community discusses potential bullish formations, including a possible breakout against Bitcoin. Positive sentiment is building, with some anticipating a Santa rally and highlighting Litecoin's real-world utility through Flexa-powered crypto acceptance at major retailers. Comparisons to other crypto projects and traditional assets like Nvidia are also circulating among traders.

Duke Energy Corp. engages in the distribution of natural gas and energy-related services. It operates through the following segments: Electric Utilities and Infrastructure, Gas Utilities and Infrastructure, and Other. The Electric Utilities and Infrastructure segment conducts operations in regulated electric utilities in the Carolinas, Florida and the Midwest. The Gas Utilities and Infrastructure segment focuses on Piedmont, natural gas local distribution companies in Ohio and Kentucky, and natural gas storage and midstream pipeline investments. The Other segment includes interest expense on holding company debt, unallocated corporate costs, and Bison which is a wholly owned captive insurance company. The company was founded on April 30, 1904 and is headquartered in Charlotte, NC.

Duke Energy Corp.

DUK is garnering attention due to discussions around grid modernization, clean energy investments, and a recent analyst upgrade citing attractive value. Community members are weighing in on its oversold status and potential for a rebound, while others discuss its dividend yield and defensive qualities in a volatile market. Several articles highlight DUK's strategic positioning in the energy sector, including its investments in nuclear and renewable energy sources, alongside comparisons to peers.

BlackBerry Ltd. engages in the provision of intelligent security software and services. It operates through the following segments: Cybersecurity, Internet of Things (IoT), and Licensing and Other. The Cybersecurity segment includes the brand Cylance, BlackBerry Spark, AtHoc, and SecuSUITE. The IoT segment focuses on software licenses, support, maintenance, and professional services. The Licensing and Other segment involves the intellectual property licensing arrangements and settlement awards. The company was founded by Michael Lazaridis, James Laurence Balsillie, and Douglas E. Fregin on March 7, 1984 and is headquartered in Waterloo, Canada.

BlackBerry Ltd

BlackBerry is trending as the community discusses the potential impact of QNX technology, particularly within automotive and IoT sectors. Investors are closely watching technical indicators like golden crosses and wedge formations, interpreting them as bullish signals. Optimism is further fueled by upcoming earnings and anticipation of significant revenue from QNX, with some suggesting a connection between BlackBerry and Nvidia.

Top Wealth Group Holding Ltd. operates as a holding company, which provides caviar and caviar-based gourmet products. It focuses on supplying sturgeon caviar to customers under its own brand, Imperial Cristal Caviar. The company was founded by Kim Kwan Kings Wong on February 1, 2023 and is headquartered in Hong Kong.

Top Wealth Group Holding Ltd. - Ordinary Shares - Class A

Top Wealth Group Holding Ltd.

TWG is trending due to a positive FY25 profit outlook, reversing previous losses, sparking community excitement and after-hours momentum. Traders are focusing on its low float and potential for a significant price surge, drawing comparisons to other recent high-flying stocks in the sector. The community is actively discussing potential price targets and overnight positions, anticipating a parabolic move.

Terra 2.0 which will assume the Terra name is a new blockchain launched by Terraform Labs as part of the passing of governance proposal 1623.  The Terra protocol is a decentralized and open-source public blockchain protocol. Luna is the Terra protocol’s native staking token used for governance and mining.  Users stake Luna to validators who record and verify transactions on the blockchain in exchange for rewards from transaction fees.  The Terra 2.0 chain will not have a stablecoin and holders of the old Terra Classic chain will be airdropped new Luna native coins. In the plan, developers of the Terra ecosystem are to migrate and deploy their dapps on the new blockchain.

Terra 2.0

LUNA is trending as the community speculates on potential ecosystem upgrades and a possible reversal following the Do Kwon saga, with some drawing parallels to comeback stories of other crypto tokens after regulatory hurdles. Discussions include potential token burns, capital liquidity increases, and the possibility of reclaiming higher price points. Community members are also weighing in on Do Kwon's legal situation and its impact on the broader crypto market.

The Sandbox is a community-driven platform where creators can monetize voxel ASSETS and gaming experiences on the blockchain.  SAND is the utility token used throughout The Sandbox ecosystem as the basis of transactions and interactions. It is an ERC-20 utility token built on the Ethereum blockchain. There is a finite supply of 3,000,000,000 SAND.

The Sandbox

SAND is trending as the gaming sector heats up, with community members discussing potential rallies and revisiting the metaverse narrative. Bullish sentiment is fueled by gaming ecosystems and talk of a potential 300% pump from current levels, while some traders eye previous highs. Community members are closely watching gaming tokens as a whole.

Disc Medicine, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery, development, and commercialization of treatments for hematologic diseases. It assembles a portfolio of clinical and preclinical product candidates that aim to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. The company was founded in October 2017 and is headquartered in Watertown, MA.

Disc Medicine Inc

$IRON is trending due to positive initial data from its RALLY-MF Phase 2 trial, with the community actively discussing the robust hematologic responses to DISC-0974. The bullish sentiment is further fueled by analysts raising price targets and the stock nearing 52-week highs. Community members are anticipating further data releases and speculating on potential price targets.

Monad is a high-performance Layer 1 blockchain that processes 10,000 transactions per second with near-zero fees. The platform delivers high performance without compromising on security or decentralization, creating the infrastructure needed for complex applications that require high-frequency activity.  One of Monad’s key innovations lies in how it handles transaction processing. Instead of processing transactions one at a time like traditional blockchains, Monad processes multiple transactions simultaneously through parallel execution.   The system separates the agreement process from the execution process, allowing validators to first agree on which transactions to include and in what order, then having more time to execute those transactions without slowing down consensus. This approach, combined with a custom-built database called MonadDB, dramatically increases throughput while maintaining accuracy.  Monad also offers complete EVM compatibility, where applications built for Ethereum work on Monad without any code modifications, and users can connect with familiar wallets like MetaMask just as they would on Ethereum. Developers can immediately tap into Ethereum's established ecosystem of tools, libraries, and applications while benefitting from Monad’s performance improvements. The platform also runs on consumer-grade hardware rather than expensive specialized equipment, making it accessible for more people to participate in securing the network.  Monad has raised approximately 244 million dollars in total funding across multiple rounds. The company secured 19 million dollars in a seed round in February 2023 led by Dragonfly Capital, followed by a 225 million dollar Series A round in April 2024 led by Paradigm at a 3 billion dollar valuation. Other notable investors include Electric Capital, Greenoaks, Coinbase Ventures, and prominent angel investors such as Naval Ravikant.

Monad

Monad ($MON) is trending as the community discusses its potential as a fast EVM-compatible blockchain, with some drawing comparisons to early Ethereum and Solana.  Enthusiasm is fueled by recent growth metrics and speculation around future exchange listings, although concerns about tokenomics and VC involvement are also being debated. Bullish investors are eagerly awaiting a breakout and anticipate significant price appreciation.

Immix Biopharma, Inc. operates as a biopharmaceutical company that engages in the development of therapies for cancer and inflammatory diseases. The company was founded by Ilya Rachman, Sean Senn, and Vladimir Torchilin in 2012 and is headquartered in Los Angeles, CA.

Immix Biopharma Inc

IMMX is trending as investors anticipate upcoming data from the ASH conference and a potential BLA submission for NXC-201, its CAR-T therapy targeting AL amyloidosis; the community is closely watching for signs of a strategic partnership or buyout, fueled by recent institutional interest and insider activity, including a new board member with a strong M&A track record; broader discussions touch upon the potential of NXC-201 as a platform technology for various autoimmune diseases, highlighting its potential beyond oncology.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Immix Biopharma (NASDAQ:IMMX) Trading 4.5% Higher - What's Next?

Immix Biopharma (NASDAQ:IMMX) Shares Up 4.5% - What's Next...

HC Wainwright Reduces Earnings Estimates for Immix Biopharma

Immix Biopharma, Inc. (NASDAQ:IMMX - Free Report) - Research analysts at HC Wainwright cut their FY2025 earnings per share (EPS) estimates for shares of Immix Biopharma in a research report issued on...

Immix Biopharma (NASDAQ:IMMX) Announces Earnings Results, Misses Expectations By $0.05 EPS

Immix Biopharma (NASDAQ:IMMX - Get Free Report) announced its quarterly earnings data on Friday. The company reported ($0.24) earnings per share (EPS) for the quarter, missing the consensus estimate...

Immix Biopharma (IMMX) Upgraded to Buy: What Does It Mean for the Stock?

IMMX Stock Earnings: Immix Biopharma Misses EPS for Q4 2023

InvestorPlace - Stock Market News, Stock Advice & Trading Tips
IMMX stock results show that Immix Biopharma missed analyst estimates for earnings per share the fourth quarter of 2023.
The post IMMX...

Immix Biopharma, Inc. (NASDAQ:IMMX) Sees Large Growth in Short Interest

Immix Biopharma, Inc. (NASDAQ:IMMX - Get Free Report) saw a significant growth in short interest during the month of March. As of March 15th, there was short interest totalling 316,600 shares, a...

Immix Biopharma Announces Major Comprehensive Cancer Center as Lead Site for NXC-201 AL Amyloidosis Clinical Trial

LOS ANGELES, CA, March 20, 2024 (GLOBE NEWSWIRE) -- Immix Biopharma, Inc. (Nasdaq: IMMX) ( ImmixBio , Company , We or Us or IMMX ), a clinical-stage biopharmaceutical company trailblazing...

$SOFI

$RDDT

$CVNA

$MSTR

Which stock do you think gets added to the S&amp;P 500 in today’s rebalance?

Stocktwits

Which stock do you think gets added to the S&P 500 in today’s rebalance?

IMMX
Immix Biopharma Inc

Feed

News

Sentiment

Fundamentals

Info

Poll

Latest IMMX News

IMMXImmix Biopharma Inc